Arbutus Biopharma (ABUS) Ownership - Who Owns Arbutus Biopharma?

1,272 Followers

Arbutus Biopharma (ABUS) Ownership Overview

0.05% Insiders

10.13% Mutual Funds

25.67% Other Institutional Investors

10.56% ETFs

53.59% Public Companies and

Individual Investors

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 46.36% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 53.59% is owned by Public Companies and Individual Investors.

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 35.80% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 10.56% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$363669
Dec 31, 2025	Saba Capital Management	xxxxxxxxxxxxx	$1673326
Dec 31, 2025	Woodline Partners Lp	xxxxxxxxxxxxx	$10517319

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	7,920,512	Institution	4.12%	34,612,637
	7,780,693	Institution	4.05%	34,001,628
	6,460,580	Institution	3.36%	28,232,735
	3,935,631	Institution	2.05%	17,198,707
	2,886,595	Institution	1.50%	12,614,420
	2,695,269	Institution	1.40%	11,778,326
Michael Rockefeller	2,186,553	Institution	1.14%	9,555,237
	1,651,470	Institution	0.86%	7,216,924
	1,534,402	Institution	0.80%	6,705,337
	883,322	Institution	0.46%	3,860,117

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
6,460,580	Institution	3.36%	28,232,735
3,935,631	Institution	2.05%	17,198,707
2,695,269	Institution	1.40%	11,778,326
1,651,470	Institution	0.86%	7,216,924
1,534,402	Institution	0.80%	6,705,337
883,322	Institution	0.46%	3,860,117
662,714	Institution	0.34%	2,896,060
484,841	Institution	0.25%	2,118,755
435,510	Institution	0.23%	1,903,179
121,867	Institution	0.06%	532,559

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	4,811,847	Institution	2.50%	22,423,207
iShares Russell 2000 ETF	3,704,921	Institution	1.93%	16,190,505
SPDR S&P BIOTECH ETF	1,948,112	Institution	1.01%	8,279,476
Vanguard Extended Market ETF	1,684,278	Institution	0.88%	7,848,735
iShares Russell 2000 Growth ETF	1,189,203	Institution	0.62%	5,196,817
iShares Biotechnology ETF	1,109,414	Institution	0.58%	4,848,139
Vanguard Russell 2000 ETF	750,938	Institution	0.39%	3,499,371
Schwab U.S. Small-Cap ETF	746,227	Institution	0.39%	3,171,465
SPDR S&P Kensho New Economies Composite ETF	631,903	Institution	0.33%	2,685,588
Vanguard Health Care ETF	432,384	Institution	0.22%	2,014,909

FAQ

Who Owns Arbutus Biopharma Corporation (ABUS)?

According to the latest TipRanks data, approximately 25.67% of the company's stock is held by institutional investors, 0.05% is held by insiders, and 53.59% is held by retail investors.

What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors?

According to the latest TipRanks data, approximately 25.67% of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors.

What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors?

According to the latest TipRanks data, approximately 53.59% of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors.

Who owns the most shares of Arbutus Biopharma Corporation (ABUS)?

Vanguard owns the most shares of Arbutus Biopharma Corporation (ABUS).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.